Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of HIV Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of HIV Vaccinesmarket, defines the market attractiveness level of HIV Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of HIV Vaccines industry, describes the types of HIV Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global HIV Vaccines market and the development prospects and opportunities of HIV Vaccines industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global HIV Vaccines market in Chapter 13.
By Player:
Genecure
Paxvax Corporation
Sanofi
Janssen Global Services
Bionor Pharma
Inovio Pharmaceuticals
Glaxosmithkline
Argos Therapeutics
Geovax,
By Type:
Phase I
Phase II
Phase III
By End-User:
Research Institute
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 HIV Vaccines Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 HIV Vaccines Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 HIV Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 HIV Vaccines Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise HIV Vaccines Market Analysis and Outlook to 2022
-
7.1 Global HIV Vaccines Consumption (2017-2022)
-
7.2 United States HIV Vaccines Consumption (2017-2022)
-
7.3 Europe HIV Vaccines Consumption (2017-2022)
-
7.4 China HIV Vaccines Consumption (2017-2022)
-
7.5 Japan HIV Vaccines Consumption (2017-2022)
-
7.6 India HIV Vaccines Consumption (2017-2022)
-
7.7 South Korea HIV Vaccines Consumption (2017-2022)
8 Region and Country-wise HIV Vaccines Market Analysis and Outlook to 2028
-
8.1 Global HIV Vaccines Consumption Forecast (2022-2028)
-
8.2 United States HIV Vaccines Consumption Forecast (2022-2028)
-
8.3 Europe HIV Vaccines Consumption Forecast (2022-2028)
-
8.4 China HIV Vaccines Consumption Forecast (2022-2028)
-
8.5 Japan HIV Vaccines Consumption Forecast (2022-2028)
-
8.6 India HIV Vaccines Consumption Forecast (2022-2028)
-
8.7 South Korea HIV Vaccines Consumption Forecast (2022-2028)
9 Global HIV Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global HIV Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Phase I Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Phase II Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Phase III Consumption and Growth Rate (2017-2022)
-
9.2 Global HIV Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Research Institute Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Other Consumption and Growth Rate (2017-2022)
10 Global HIV Vaccines Market Outlook by Types and Applications to 2028
-
10.1 Global HIV Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Phase I Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Phase II Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Phase III Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global HIV Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Research Institute Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global HIV Vaccines Import and Export Analysis (Top 5 Countries)
-
11.1 Global HIV Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global HIV Vaccines Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 HIV Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global HIV Vaccines Market Competitive Analysis
-
14.1 Genecure
-
14.1.1 Genecure Company Details
-
14.1.2 Genecure HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Genecure HIV Vaccines Product and Service
-
14.2 Paxvax Corporation
-
14.2.1 Paxvax Corporation Company Details
-
14.2.2 Paxvax Corporation HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Paxvax Corporation HIV Vaccines Product and Service
-
14.3 Sanofi
-
14.3.1 Sanofi Company Details
-
14.3.2 Sanofi HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi HIV Vaccines Product and Service
-
14.4 Janssen Global Services
-
14.4.1 Janssen Global Services Company Details
-
14.4.2 Janssen Global Services HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Janssen Global Services HIV Vaccines Product and Service
-
14.5 Bionor Pharma
-
14.5.1 Bionor Pharma Company Details
-
14.5.2 Bionor Pharma HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bionor Pharma HIV Vaccines Product and Service
-
14.6 Inovio Pharmaceuticals
-
14.6.1 Inovio Pharmaceuticals Company Details
-
14.6.2 Inovio Pharmaceuticals HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Inovio Pharmaceuticals HIV Vaccines Product and Service
-
14.7 Glaxosmithkline
-
14.7.1 Glaxosmithkline Company Details
-
14.7.2 Glaxosmithkline HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Glaxosmithkline HIV Vaccines Product and Service
-
14.8 Argos Therapeutics
-
14.8.1 Argos Therapeutics Company Details
-
14.8.2 Argos Therapeutics HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Argos Therapeutics HIV Vaccines Product and Service
-
14.9 Geovax,
-
14.9.1 Geovax, Company Details
-
14.9.2 Geovax, HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Geovax, HIV Vaccines Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of HIV Vaccines
-
Figure HIV Vaccines Picture
-
Table Global HIV Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global HIV Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global HIV Vaccines Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global HIV Vaccines Consumption by Country (2017-2022)
-
Figure United States HIV Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe HIV Vaccines Consumption and Growth Rate (2017-2022)
-
Figure China HIV Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan HIV Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India HIV Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea HIV Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global HIV Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States HIV Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe HIV Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure China HIV Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan HIV Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India HIV Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea HIV Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phase I Consumption and Growth Rate (2017-2022)
-
Figure Global Phase II Consumption and Growth Rate (2017-2022)
-
Figure Global Phase III Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institute Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Phase I Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phase II Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phase III Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institute Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global HIV Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
Table Global HIV Vaccines Export by Region (Top 5 Countries) (2017-2028)
-
Table Genecure (Foundation Year, Company Profile and etc.)
-
Table Genecure HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genecure HIV Vaccines Product and Service
-
Table Paxvax Corporation (Foundation Year, Company Profile and etc.)
-
Table Paxvax Corporation HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Paxvax Corporation HIV Vaccines Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi HIV Vaccines Product and Service
-
Table Janssen Global Services (Foundation Year, Company Profile and etc.)
-
Table Janssen Global Services HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Global Services HIV Vaccines Product and Service
-
Table Bionor Pharma (Foundation Year, Company Profile and etc.)
-
Table Bionor Pharma HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bionor Pharma HIV Vaccines Product and Service
-
Table Inovio Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Inovio Pharmaceuticals HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Inovio Pharmaceuticals HIV Vaccines Product and Service
-
Table Glaxosmithkline (Foundation Year, Company Profile and etc.)
-
Table Glaxosmithkline HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glaxosmithkline HIV Vaccines Product and Service
-
Table Argos Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Argos Therapeutics HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Argos Therapeutics HIV Vaccines Product and Service
-
Table Geovax, (Foundation Year, Company Profile and etc.)
-
Table Geovax, HIV Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Geovax, HIV Vaccines Product and Service
-
